$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2022 Q3 Form 10-Q Financial Statement

#000141057822002660 Filed on August 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $5.857M $4.635M $4.291M
YoY Change 11.09% -0.7% 43.15%
Cost Of Revenue $4.296M $3.214M $2.809M
YoY Change 16.22% -5.74% 36.44%
Gross Profit $1.562M $1.421M $1.481M
YoY Change -0.92% 12.95% 57.86%
Gross Profit Margin 26.66% 30.66% 34.52%
Selling, General & Admin $1.189M $1.383M $1.464M
YoY Change -12.37% 22.02% 0.15%
% of Gross Profit 76.15% 97.28% 98.87%
Research & Development $103.2K $89.26K $142.7K
YoY Change 6.36% -11.67% 2.46%
% of Gross Profit 6.61% 6.28% 9.63%
Depreciation & Amortization $4.950K $5.113K $730.00
YoY Change 15.93% 165.89% -99.54%
% of Gross Profit 0.32% 0.36% 0.05%
Operating Expenses $1.292M $1.472M $1.607M
YoY Change -11.12% 19.26% 0.35%
Operating Profit $269.1K -$50.64K -$126.0K
YoY Change 120.59% -309.87% -81.01%
Interest Expense $68.53K $55.50K -$109.9K
YoY Change 378.89% 484.85% 633.09%
% of Operating Profit 25.46%
Other Income/Expense, Net
YoY Change
Pretax Income $200.6K -$106.1K -$235.8K
YoY Change 86.26% -825.0% -48.38%
Income Tax $0.00
% Of Pretax Income
Net Earnings $200.6K -$106.1K -$235.8K
YoY Change 86.27% -824.94% -48.38%
Net Earnings / Revenue 3.42% -2.29% -5.5%
Basic Earnings Per Share $0.09 -$0.05
Diluted Earnings Per Share $0.09 -$0.05 -$102.0K
COMMON SHARES
Basic Shares Outstanding 2.313M 2.313M 2.313M
Diluted Shares Outstanding 2.313M 2.313M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $178.9K $255.9K $438.7K
YoY Change 6.12% 408.0% 173.19%
Cash & Equivalents $178.9K $255.9K $438.7K
Short-Term Investments
Other Short-Term Assets $328.2K $291.8K $241.3K
YoY Change -37.98% -23.97% -28.32%
Inventory $5.171M $6.753M $6.229M
Prepaid Expenses $328.2K $291.8K $241.3K
Receivables $631.2K $493.3K $1.290M
Other Receivables $4.736M $3.165M $2.800M
Total Short-Term Assets $11.05M $10.96M $11.00M
YoY Change 15.7% 47.19% 51.46%
LONG-TERM ASSETS
Property, Plant & Equipment $398.1K $437.9K $477.6K
YoY Change 308.32% 210.35% 158.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $440.1K $481.0K $521.9K
YoY Change 205.68% 154.92% 123.6%
TOTAL ASSETS
Total Short-Term Assets $11.05M $10.96M $11.00M
Total Long-Term Assets $440.1K $481.0K $521.9K
Total Assets $11.49M $11.44M $11.52M
YoY Change 18.52% 49.85% 53.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.896M $1.692M $1.572M
YoY Change 378.3% 318.16% 208.57%
Accrued Expenses $541.5K $471.2K $751.4K
YoY Change 90.01% 51.27% 81.6%
Deferred Revenue
YoY Change
Short-Term Debt $3.358M $3.618M $3.239M
YoY Change -3.93% 204.88% 17035.08%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.505M $6.622M $6.547M
YoY Change 34.07% 128.12% 285.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $248.0K $285.8K $335.4K
YoY Change -68.98%
Total Long-Term Liabilities $248.0K $285.8K $335.4K
YoY Change -68.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.505M $6.622M $6.547M
Total Long-Term Liabilities $248.0K $285.8K $335.4K
Total Liabilities $6.753M $6.908M $6.883M
YoY Change 39.18% 137.96% 147.69%
SHAREHOLDERS EQUITY
Retained Earnings -$8.176M -$8.377M -$8.271M
YoY Change 1.31% 2.43% 0.95%
Common Stock $12.91M $12.91M $12.91M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.733M $4.532M $4.638M
YoY Change
Total Liabilities & Shareholders Equity $11.49M $11.44M $11.52M
YoY Change 18.52% 49.85% 53.71%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $200.6K -$106.1K -$235.8K
YoY Change 86.27% -824.94% -48.38%
Depreciation, Depletion And Amortization $4.950K $5.113K $730.00
YoY Change 15.93% 165.89% -99.54%
Cash From Operating Activities $183.6K -$562.4K $251.9K
YoY Change -108.38% 186.04% -157.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -260.6K 379.5K -200.3K
YoY Change -111.29% 339.39% -1159.49%
NET CHANGE
Cash From Operating Activities 183.6K -562.4K 251.9K
Cash From Investing Activities
Cash From Financing Activities -260.6K 379.5K -200.3K
Net Change In Cash -77.00K -182.9K 51.51K
YoY Change -165.15% 65.88% -112.26%
FREE CASH FLOW
Cash From Operating Activities $183.6K -$562.4K $251.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000102109
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-31747
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0898545
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
11407 Cronhill Drive
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Owings Mills
CY2022Q2 dei Entity Address Country
EntityAddressCountry
MD
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21117
CY2022Q2 dei City Area Code
CityAreaCode
410
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
363-3000
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q2 dei Trading Symbol
TradingSymbol
UUU
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
255881
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
438735
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
493349
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1290481
CY2022Q2 uuu Receivables From Employees
ReceivablesFromEmployees
7030
CY2022Q1 uuu Receivables From Employees
ReceivablesFromEmployees
6731
CY2022Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
500379
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1297212
CY2022Q2 uuu Due From Factor
DueFromFactor
3157484
CY2022Q1 uuu Due From Factor
DueFromFactor
2792901
CY2022Q2 us-gaap Inventory Net
InventoryNet
6753229
CY2022Q1 us-gaap Inventory Net
InventoryNet
6229061
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
291829
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
241342
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10958802
CY2022Q1 us-gaap Assets Current
AssetsCurrent
10999251
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
39127
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40243
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
437880
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477627
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2022Q2 us-gaap Assets
Assets
11439809
CY2022Q1 us-gaap Assets
Assets
11521121
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2836627
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2157086
CY2022Q2 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
781440
CY2022Q1 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
1081440
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
145787
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1692124
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1572356
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
840410
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
985077
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
142923
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160025
CY2022Q2 uuu Commissions And Other
CommissionsAndOther
182476
CY2022Q1 uuu Commissions And Other
CommissionsAndOther
459440
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6621787
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6547304
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
285754
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
285754
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
335411
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
23129
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8376702
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8270564
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4532268
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11439809
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11521121
CY2022Q2 us-gaap Revenues
Revenues
4635304
CY2021Q2 us-gaap Revenues
Revenues
4667998
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3214081
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3409673
CY2022Q2 us-gaap Gross Profit
GrossProfit
1421223
CY2021Q2 us-gaap Gross Profit
GrossProfit
1258325
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1382603
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1133139
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89262
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101056
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-50642
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24130
CY2022Q2 us-gaap Interest Expense
InterestExpense
55496
CY2021Q2 us-gaap Interest Expense
InterestExpense
9489
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-106138
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
14641
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-106138
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4532268
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
14641
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4731197
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-106138
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
14641
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5113
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1923
CY2022Q2 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-432250
CY2021Q2 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
321292
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
574655
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27731
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-318965
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80385
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-562395
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-196612
CY2022Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
300000
CY2022Q2 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
679541
CY2021Q2 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
86379
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
379541
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86379
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-182854
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-110233
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438735
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160604
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
255881
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50371
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
55496
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
9489
CY2022Q2 uuu Trade Accounts Receivable Net
TradeAccountsReceivableNet
493000
CY2022Q2 uuu Short Term Notes Payable Per Month
ShortTermNotesPayablePerMonth
100000
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1081000
CY2015Q1 uuu Percentage Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.80
CY2015Q1 uuu Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
1
CY2015Q1 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2015Q1 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
500000
CY2022Q2 uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
CY2022Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2837000
CY2022Q2 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.02
CY2022Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0675
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11810
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
431541
CY2022Q2 us-gaap Revenues
Revenues
4635304
CY2021Q2 us-gaap Revenues
Revenues
4667998
CY2022Q2 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
636000
CY2021Q2 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
579000
CY2022Q2 uuu Maximum Amount Outstanding
MaximumAmountOutstanding
217066
CY2021Q2 uuu Maximum Amount Outstanding
MaximumAmountOutstanding
210773
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2021Q2 uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
CY2022Q2 uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
100000
CY2022Q2 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
781440
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
14500
CY2022Q2 uuu Operating Lease Rent Increment Percentage
OperatingLeaseRentIncrementPercentage
0.030
CY2022Q2 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2022Q2 uuu Non Cash Right Of Use Asset In Exchange For Operating Lease Liability
NonCashRightOfUseAssetInExchangeForOperatingLeaseLiability
485000
CY2022Q2 uuu Adoption Of Lease Expenses Increased
AdoptionOfLeaseExpensesIncreased
468000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
428350
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
431541
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
37838
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
37838
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
100900
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
155512
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
160179
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
26760
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
443351

Files In Submission

Name View Source Status
0001410578-22-002660-index-headers.html Edgar Link pending
0001410578-22-002660-index.html Edgar Link pending
0001410578-22-002660.txt Edgar Link pending
0001410578-22-002660-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20220630.xsd Edgar Link pending
uuu-20220630x10q.htm Edgar Link pending
uuu-20220630xex31d1.htm Edgar Link pending
uuu-20220630xex31d2.htm Edgar Link pending
uuu-20220630xex32d1.htm Edgar Link pending
uuu-20220630xex99d1.htm Edgar Link pending
uuu-20220630xex99d1001.jpg Edgar Link pending
uuu-20220630xex99d1002.jpg Edgar Link pending
uuu-20220630_cal.xml Edgar Link unprocessable
uuu-20220630x10q_htm.xml Edgar Link completed
uuu-20220630_pre.xml Edgar Link unprocessable
uuu-20220630_lab.xml Edgar Link unprocessable
uuu-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable